Feeds:
Posts
Comments

Archive for June, 2010

PROSTABLOG NZ: For NZ males, prostate cancer accounted for 28.6 percent of all cancer registrations in 2007, reports the NZ Ministry of Health, with the next-most-common registrations being colorectal cancer and malignant melanoma of the skin. READ MORE>

Read Full Post »

WALL ST JOURNAL: Scientists may soon be able to answer the agonising question facing men with prostate cancer: does their cancer need immediate treatment or can it be left alone? READ MORE> and HERE> and HERE>

Read Full Post »

NEW PROSTATE CANCER INFOLINK: For all of the academic literature and the recommendations of guideline-generating organizations on testing, diagnosis, and management of prostate cancer, urologists out in community practice may show considerable variation in their clinical practice patterns. READ MORE>

Read Full Post »

LA TIMES:  Two studies and a review of previous studies address the widely prescribed cholesterol drugs: one questions their use as a preventive measure; another suggests they help prostate cancer patients. READ MORE>

Read Full Post »

URO TODAY: Of all cancers, prostate cancer is the most sensitive to hormones: it is thus very important to take advantage of this unique property and to always use optimal androgen blockade when hormone therapy is the appropriate treatment.  READ MORE>

Read Full Post »

ABC NEWS: Many doctors are failing to recognise the effects that breast and prostate cancer have on a patient’s mental health, according to a recent study. READ MORE>

Read Full Post »

TORONTO SUN: Green tea and red wine are very effective at blocking prostate cancer’s growth, recent studies have shown. READ MORE>

Read Full Post »

BLOOMBERG: Prostate cancer patients seeking Dendreon Corp’s new tumour-fighting vaccine, Provenge, face delays of a year or more as hospital waiting lists dwarf the company’s capacity to produce medicine. READ MORE>

Read Full Post »

SCIENCE CENTRIC: A unique collaboration among physician-scientists at Memorial Sloan-Kettering Cancer Centre has yielded the most comprehensive genomic analysis of prostate cancer to date. READ MORE>

Read Full Post »

URO TODAY: The American Cancer Society updated its recommendations on prostate cancer screening after a series of reviews. READ MORE>

It says:

Prostate cancer screening should not occur without an informed decision-making process.

Men at average risk should receive this information beginning at age 50.

Men in higher-risk groups should receive this information before age 50.

Men should either receive this information directly from their health care providers or be referred to reliable and culturally appropriate sources.

Patient decision aids are helpful in preparing men to make a decision whether to be tested, and the use of such aids is encouraged.

Read Full Post »

Older Posts »